Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 46,000 shares at $5.84 ($263K) on 2022-04-05, disclosed to the SEC on 2022-04-07.
Open-market purchase of $263k BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.64 | 30,000 | $169K | 64.4% |
| 2 | $5.84 | 16,000 | $93K | 35.6% |
| Total | $5.71 avg | 46,000 | $263K | 100% |
| Filing → |
| BRTX | BUY | 2024-02-09 | $325K | — | Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |